SCHEMBL22019990

SCHEMBL22019990

Cc1cc(CC(F)(F)F)nc2c1CCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ACHE P22303 7/20 0.35
BCHE P06276 5/20 0.35
GRIN1 Q05586 4/20 0.35
GRIN2A Q12879 4/20 0.35
KDM4E B2RXH2 3/20 0.34
POLB P06746 4/20 0.34
MAPK1 P28482 2/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30162186 0.82 ACHE (0.39) NOS3NOS1NOS2ACHEBCHE
SCHEMBL21963370 0.82 ACHE (0.39) NOS3NOS1NOS2ACHEBCHE
SCHEMBL526538 0.74 NOS3 (0.55) NOS3NOS1NOS2NPC1RAB9A
SCHEMBL22020717 0.74 NOS3 (0.50) NOS3NOS1NOS2NPC1RAB9A
SCHEMBL22020649 0.71 GAA (0.35) NPC1RAB9AACHEKDM4EMAPT
SCHEMBL526208 0.71 NOS3 (0.51) NOS3NOS1NOS2NPC1RAB9A
SCHEMBL22020056 0.71 KMT2A (0.36) NOS3NOS1NOS2NPC1RAB9A
SCHEMBL20416983 0.70 NOS3 (0.59) NOS3NOS1NOS2NPC1RAB9A
SCHEMBL22019991 0.68 KMT2A (0.33) NOS3NOS1NOS2ACHEKDM4E
SCHEMBL21963362 0.68 ACHE (0.46) NOS3NOS1NOS2ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed